PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data and Error
Open Access
- 1 December 2009
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 2 (4) , 223-230
- https://doi.org/10.1593/tlo.09223
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- X-ray-based attenuation correction for positron emission tomography/computed tomography scannersSeminars in Nuclear Medicine, 2003
- Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scansEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Prognostic Factors in Non-small Cell Lung CancerChest, 2002
- 2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome.2002
- Is quantitation necessary for oncological PET studies?European Journal of Nuclear Medicine and Molecular Imaging, 2001
- Anatomy of SUVNuclear Medicine and Biology, 2000
- Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast CancerJournal of Clinical Oncology, 2000
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal Of Cancer, 1999
- Reproducibility of metabolic measurements in malignant tumors using FDG PET.1999
- Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging The Visual Response Score and the Change in Total Lesion GlycolysisClinical Positron Imaging, 1999